SLASCall for PapersSLAS Journals Spotlight AI in Drug DiscoveryAs artificial intelligence reshapes life sciences research, two leading Elsevier Gold Open Access peer-reviewed journals, SLAS Discovery and SLAS Technology, invite contributions to Special Issues exploring … more ➔
Commercial Strategy3PBIOVIAN appoints Ponchi Kantt-Neaz as Global Executive Business DirectorThe appointment of Ponchi marking an important milestone in the company’s global commercial strategy and further strengthening its commercial leadership as the company continues to expand its presence … more ➔
EBD Group/InformaBIO-EuropeBIO-Europe 2026Join us for the 2nd BIO-Europe in Cologne, Germany, November 9–11, 2026, the premier biopharma partnering event now transformed into a comprehensive forum for biotech leaders. more ➔
ELRIGDrug DiscoveryThe connective matrix: ELRIG’s role in the drug discovery ecosystemDrug discovery depends on more than breakthrough science alone. Progress increasingly emerges from connected ecosystems where academia, biotech, pharma, CROs and technology providers can openly exchange … more ➔
IndivumedIndivumed, ready to set sail to the clinicWith the separation from the biobank service business, Hamburg-based Indivumed has repositioned itself as a therapeutics biotech. Its earlier work remains the core of its medical knowledge and the source … more ➔
Andre DallavalleOncologyTheranostics as potential novel therapeutic pillar in oncologySee-and-Treat Concept using Radioactive Smart Probes: Professor Rudolf Werner provides an overview of established and future indications in clinical practice, highlighting advances in theranostics and … more ➔
CM4Cure. All Rights Reserved.Drug deliveryDrug delivery nanogel to transform medical devicesCM4Cure is focused on substantially improving patient outcomes, improving medical device performance by incorporating drug delivery. Our technology redefines medical device coatings – converting … more ➔
SecarnaRNA TechnologiesNext-gen oligonucleotides to transform patient careSecarna Pharmaceuticals is redefining the discovery and development of oligonucleotide therapeutics to address hard-to-treat disorders. The Company is planning to raise a Series A to advance its lead … more ➔
Mammalian cell culture3PBIOVIAN expands its mammalian capacity with an additional 2,000 L bioreactor3PBIOVIAN has added an additional 2,000-liter single-use bioreactor for mammalian cell culture, further strengthening its industrial capacity and reinforcing its value proposition as a CDMO partner for … more ➔
Chemspec EuropeChemspec EuropeStanding Together in Uncertain TimesChemspec Europe returned to Cologne between 6-7 May 2026, drawing 4,238 attendees from 60 nations and 454 exhibitors from 28 countries, an increase from last year’s event. more ➔
SLAS
EBD Group/Informa
ELRIG
Andre Dallavalle
CM4Cure. All Rights Reserved.
Secarna
Chemspec Europe